Protein FDR Confidence: Combined | Accession | Description | Exp. q-value: Combined | Sum PEP Score | Coverage [%] | # Peptides | # PSMs | # Unique Peptides | # AAs | MW [kDa] | calc. pI | Abundance Ratio: (DKO) / (WT) | Abundance Ratio: (SKO) / (WT) | Abundance Ratio (log2): (DKO) / (WT) | Abundance Ratio (log2): (SKO) / (WT) | Abundance Ratio P-Value: (DKO) / (WT) | Abundance Ratio P-Value: (SKO) / (WT) | Abundance Ratio Adj. P-Value: (DKO) / (WT) | Abundance Ratio Adj. P-Value: (SKO) / (WT) | Abundances (Grouped): DKO | Abundances (Grouped): SKO | Abundances (Grouped): WT | Abundances (Grouped) CV [%]: DKO | Abundances (Grouped) CV [%]: SKO | Abundances (Grouped) CV [%]: WT | Abundances (Scaled): F1: 127C, Sample, DKO, 1 | Abundances (Scaled): F1: 128C, Sample, DKO, 2 | Abundances (Scaled): F1: 129C, Sample, DKO, 3 | Abundances (Scaled): F1: 130C, Sample, DKO, 4 | Abundances (Scaled): F1: 129N, Sample, SKO, 1 | Abundances (Scaled): F1: 130N, Sample, SKO, 2 | Abundances (Scaled): F1: 131, Sample, SKO, 3 | Abundances (Scaled): F1: 126, Sample, WT, 1 | Abundances (Scaled): F1: 127N, Sample, WT, 2 | Abundances (Scaled): F1: 128N, Sample, WT, 3 | Abundances (Normalized): F1: 127C, Sample, DKO, 1 | Abundances (Normalized): F1: 128C, Sample, DKO, 2 | Abundances (Normalized): F1: 129C, Sample, DKO, 3 | Abundances (Normalized): F1: 130C, Sample, DKO, 4 | Abundances (Normalized): F1: 129N, Sample, SKO, 1 | Abundances (Normalized): F1: 130N, Sample, SKO, 2 | Abundances (Normalized): F1: 131, Sample, SKO, 3 | Abundances (Normalized): F1: 126, Sample, WT, 1 | Abundances (Normalized): F1: 127N, Sample, WT, 2 | Abundances (Normalized): F1: 128N, Sample, WT, 3 | Abundance: F1: 127C, Sample, DKO, 1 | Abundance: F1: 128C, Sample, DKO, 2 | Abundance: F1: 129C, Sample, DKO, 3 | Abundance: F1: 130C, Sample, DKO, 4 | Abundance: F1: 129N, Sample, SKO, 1 | Abundance: F1: 130N, Sample, SKO, 2 | Abundance: F1: 131, Sample, SKO, 3 | Abundance: F1: 126, Sample, WT, 1 | Abundance: F1: 127N, Sample, WT, 2 | Abundance: F1: 128N, Sample, WT, 3 | Abundances Count: F1: 127C, Sample, DKO, 1 | Abundances Count: F1: 128C, Sample, DKO, 2 | Abundances Count: F1: 129C, Sample, DKO, 3 | Abundances Count: F1: 130C, Sample, DKO, 4 | Abundances Count: F1: 129N, Sample, SKO, 1 | Abundances Count: F1: 130N, Sample, SKO, 2 | Abundances Count: F1: 131, Sample, SKO, 3 | Abundances Count: F1: 126, Sample, WT, 1 | Abundances Count: F1: 127N, Sample, WT, 2 | Abundances Count: F1: 128N, Sample, WT, 3 | Biological Process | Cellular Component | Molecular Function | Pfam IDs | Entrez Gene ID | Gene Symbol | Chromosome | Reactome Pathways | Ensembl Gene ID | KEGG Pathways | WikiPathways | # Razor Peptides | Modifications |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
High | P67871 | Casein kinase II subunit beta OS=Mus musculus OX=10090 GN=Csnk2b PE=1 SV=1 | 0 | 31.349 | 46 | 7 | 14 | 7 | 215 | 24.9 | 5.55 | 1.312 | 1.169 | 0.39 | 0.23 | 0.257007861 | 0.387501827 | 0.951206606 | 0.972646624 | 113.1 | 100.7 | 86.2 | 7.72 | 6.64 | 13.56 | 105 | 102.2 | 112.2 | 121.3 | 92.9 | 105.6 | 96.7 | 79.6 | 82.8 | 101.7 | 288.7 | 280.9 | 308.3 | 333.3 | 255.3 | 290.3 | 265.8 | 218.7 | 227.4 | 279.4 | 224.8 | 241.8 | 274.6 | 288.3 | 238.4 | 236.5 | 265.8 | 199.9 | 200.4 | 257.7 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | metabolic process;regulation of biological process;response to stimulus | chromosome;cytoplasm;membrane;nucleus | catalytic activity;enzyme regulator activity;metal ion binding;protein binding | Pf01214 | 13001 | Csnk2b | 17 | WNT mediated activation of DVL; Regulation of TP53 Activity through Phosphorylation; Neutrophil degranulation; Synthesis of PC; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; Condensation of Prometaphase Chromosomes; Receptor Mediated Mitophagy; Regulation of PTEN stability and activity; Signal transduction by L1; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | ENSMUSG00000024387.13 | Herpes simplex infection; Wnt signaling pathway; Epstein-Barr virus infection; Adherens junction; Ribosome biogenesis in eukaryotes; NF-kappa B signaling pathway; Tight junction; Measles | TNF-alpha NF-kB Signaling Pathway; Wnt Signaling Pathway NetPath | 0 |